Targeting IL-12/IL-23 by employing a p40 peptide-based vaccine ameliorates TNBS-induced acute and chronic murine colitis.
about
Nematode modulation of inflammatory bowel diseaseAutoimmune/inflammatory syndrome induced by adjuvants (Shoenfeld's syndrome): clinical and immunological spectrum.The potential protective role of caveolin-1 in intestinal inflammation in TNBS-induced murine colitis.Identification of IL18RAP/IL18R1 and IL12B as leprosy risk genes demonstrates shared pathogenesis between inflammation and infectious diseasesThe role of interleukin 17 in Crohn's disease-associated intestinal fibrosisA virus-like particle-based connective tissue growth factor vaccine suppresses carbon tetrachloride-induced hepatic fibrosis in miceCellular and Molecular Mediators of Intestinal Fibrosis.Recent Advances: The Imbalance of Cytokines in the Pathogenesis of Inflammatory Bowel Disease.miR-301a promotes intestinal mucosal inflammation through induction of IL-17A and TNF-α in IBD.Cellular and molecular mechanisms of intestinal fibrosis.An IL-17 peptide-based and virus-like particle vaccine enhances the bioactivity of IL-17 in vitro and in vivo.The role and potential therapeutic application of myeloid-derived suppressor cells in TNBS-induced colitis.Employing an IL-23 p19 vaccine to block IL-23 ameliorates chronic murine colitis.Comparison of the innate immune responses of porcine monocyte-derived dendritic cells and splenic dendritic cells stimulated with LPS.Exogenous murine antimicrobial peptide CRAMP significantly exacerbates Ovalbumin-induced airway inflammation but ameliorates oxazolone-induced intestinal colitis in BALB/c mice.
P2860
Q26865117-DB058274-A526-4087-B27B-B84CB3F49186Q34337165-8BB02E69-4875-4474-8979-BAAE41DA9FA3Q35163625-A85989B4-1FEC-475E-9150-9E393F45C221Q36365633-FA1A3F46-A0F2-4064-8836-03FCC966F6D4Q37070931-6A68F1AB-20E4-4EEF-ACA9-C7564CC1830AQ37209120-ECB95D57-CB51-404B-98BA-EA452C8B857EQ38259227-75024388-5D00-41E0-8665-76702E65D206Q39249504-8DE200F3-91A2-4DB3-9320-C41A9B07F1F8Q40575298-6D56840C-3959-4F31-B89A-A2FA449BE878Q42252132-A30E915C-62D0-4CC2-9CDC-6177E1DEF457Q42827899-2492005C-6963-4D8B-93F1-7B2979BE98EBQ44578886-95533B77-0413-494E-8CD4-E66086E6CF7EQ46699505-7DCB12E8-DA18-4998-82AD-5660748B28B6Q46801888-BE6160F9-CF64-42E1-AD2A-71AE759D240CQ47429893-1C14F876-03A0-4A8E-ACDB-616B03659C92
P2860
Targeting IL-12/IL-23 by employing a p40 peptide-based vaccine ameliorates TNBS-induced acute and chronic murine colitis.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Targeting IL-12/IL-23 by emplo ...... te and chronic murine colitis.
@ast
Targeting IL-12/IL-23 by emplo ...... te and chronic murine colitis.
@en
type
label
Targeting IL-12/IL-23 by emplo ...... te and chronic murine colitis.
@ast
Targeting IL-12/IL-23 by emplo ...... te and chronic murine colitis.
@en
prefLabel
Targeting IL-12/IL-23 by emplo ...... te and chronic murine colitis.
@ast
Targeting IL-12/IL-23 by emplo ...... te and chronic murine colitis.
@en
P2093
P2860
P1433
P1476
Targeting IL-12/IL-23 by emplo ...... te and chronic murine colitis.
@en
P2093
Aiping Bai
Allan G Ma
Carolyn R Weiss
Charles N Bernstein
China-Li Hillman
Gefei Qing
Qingdong Guan
Richard J Warrington
Yanbing Ma
P2860
P2888
P304
P356
10.2119/MOLMED.2010.00252
P407
P577
2011-03-11T00:00:00Z
P5875
P6179
1068965340